SWX/MOLN (SWX/MOLN)

SIX Swiss Exchange: SWX/MOLN · CHF

CHF 2.58

-0.20 (-7.2%)· Recorded snapshot

Market cap	98.8M
Net income (ttm)	-51.1M
EPS (ttm)	-CHF 1.35
Shares out	38.3M
P/E (forward)	2.3x
Volume	46,136
Beta	0.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -51.1M
EPS (ttm): -CHF 1.35
P/E (forward): 2.3x
Market cap: 98.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E2.3

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-69.9

P25 n/aP50 n/aP75 n/a

ROIC-43

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/MOLN indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

CHF

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	Switzerland
Country code	CH
Earnings date	2026-11-05
Employees	134
Employees change	-25
Employees growth	-15.46%
Enterprise value	CHF 44.1M
Exchange	SIX Swiss Exchange
Financial currency	CHF
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	2004
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CH0256379097
Last earnings date	2026-08-25
Last refreshed	2026-11-03
Market cap	CHF 98.8M
Next earnings date	2026-11-05
Price	CHF 2.58
Price currency	CHF
Sector	Healthcare
SIC code	2836
Stock price date	2026-11-03
Symbol	swx/MOLN
Website	https://www.molecularpartners.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-52.15%
FCF / EV yield	-90.56%
FCF yield	-44%
Forward P/E	2.32x
Industry forward P/E	85.45x
P/B ratio	2.1x
Price / tangible book value	2.1x
Sector forward P/E	19.93x
Sector P/E	34.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	CHF -381,037
ROA	-36.62%
ROA (5Y)	-10.62%
ROCE	-93.92%
ROE	-69.85%
ROE (5Y)	-22.06%
ROIC	-43%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Net income growth quarters	2
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -159,000
Depreciation and amortization	CHF 729,000
EBIT	CHF -51.8M
EBITDA	CHF -51M
EPS	CHF -1.35
FCF per share	CHF -1.22
Financing cash flow	CHF -1.1M
Free cash flow	CHF -46.9M
Free cash flow minus SBC	CHF -50.6M
Gross profit	CHF -39.1M
Income taxes	CHF 4,000
Investing cash flow	CHF 22.5M
Net borrowing	CHF -1.2M
Net cash flow	CHF -24.9M
Net income	CHF -51.1M
Operating cash flow minus SBC	CHF -50.4M
Operating income	CHF -51.8M
Stock-based compensation	CHF 3.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CHF 1.34
Debt / equity	0.05
Long-term assets	CHF 3.8M
Long-term liabilities	CHF 4.4M
Net cash (debt)	CHF 54.8M
Net cash / market cap	51.42%
Net cash growth	-46.84%
Net debt / equity	-1.08
Piotroski F-Score	1
Property, plant and equipment	CHF 3.8M
Shareholders' equity	CHF 50.7M
Tangible book value	CHF 50.7M
Tangible book value per share	CHF 1.34
Total assets	CHF 64.5M
Total cash	CHF 57.5M
Total debt	CHF 2.7M
Total liabilities	CHF 13.9M
WACC	7.36%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CHF 60.7M
Current liabilities	CHF 9.4M
Current ratio	6.46
Net working capital	CHF -5M
Quick ratio	6.28
Working capital	CHF 51.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.19%
Shareholder yield	-2.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-88.8%
10Y return CAGR	-19.67%
10Y total return	-88.8%
150-day SMA	CHF 3.23
1D price change	-7.19%
1M price change	-21.32%
1M total return	-21.32%
1W price change	-16.83%
1W total return	-16.83%
1Y price change	-9.66%
1Y return CAGR	-9.66%
1Y total return	-9.66%
20-day SMA	CHF 3.08
200-day SMA	CHF 3.30
3M price change	-21.32%
3M total return	-21.32%
3Y price change	-25.14%
3Y return CAGR	-9.2%
3Y total return	-25.14%
50-day SMA	CHF 3.27
50-day SMA vs 200-day SMA	50under200
52-week high	CHF 3.96
52-week high date	2026-03-06
52-week low	CHF 2.56
52-week low date	2026-11-03
5Y price change	-85.41%
5Y return CAGR	-31.96%
5Y total return	-85.41%
6M price change	-18.38%
6M total return	-18.38%
All-time high	CHF 38.75
All-time high date	2015-11-05
All-time low	CHF 2.56
All-time low date	2026-11-03
Average true range (ATR)	CHF 0.14
Average volume	20.6K
Beta (1Y)	0.43
Beta (2Y)	0.83
Beta (5Y)	0.6
Change from 52-week high	-34.85%
Change from 52-week low	0.78%
Change from all-time high	-93.24%
Change from all-time low	2.34%
Change from open	-7.19%
Day's gap	0%
Dollar volume	CHF 119,031
High price	CHF 2.78
Low price	CHF 2.56
Monthly RSI	38.56
Open price	CHF 2.78
Position in 52-week range	9.09%
Previous close	CHF 2.78
Price vs 150-day SMA	-18.84%
Price vs 20-day SMA	-14.82%
Price vs 200-day SMA	-20.65%
Price vs 50-day SMA	-19.78%
Relative volume	2.24
RSI	23.55
Sharpe ratio	-0.06
Sharpe ratio (3Y)	0.1
Sharpe ratio (5Y)	-0.29
Sortino ratio	0.02
Sortino ratio (3Y)	0.26
Sortino ratio (5Y)	-0.33
Volume	46.1K
Weekly RSI	34
YTD price change	-22.6%
YTD total return	-22.6%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20.7M
Shares change (QoQ)	-1.4%
Shares change (YoY)	2.19%
Shares held by insiders	4.39%
Shares held by institutions	9.1%
Shares outstanding	38.3M

Deeper analysis on SWX/MOLN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/MOLN report

Is a complete SWX/MOLN research report available?

No complete published report is available for swx/MOLN (SWX/MOLN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/MOLN (SWX/MOLN)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/MOLN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/MOLN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/MOLN

Frequently asked questions